Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation

K. Kluckova, M. Sticha, J. Cerny, T. Mracek, L. Dong, Z. Drahota, E. Gottlieb, J. Neuzil, J. Rohlena,

. 2015 ; 6 (-) : e1749. [pub] 20150507

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Respiratory complex II (CII, succinate dehydrogenase, SDH) inhibition can induce cell death, but the mechanistic details need clarification. To elucidate the role of reactive oxygen species (ROS) formation upon the ubiquinone-binding (Qp) site blockade, we substituted CII subunit C (SDHC) residues lining the Qp site by site-directed mutagenesis. Cell lines carrying these mutations were characterized on the bases of CII activity and exposed to Qp site inhibitors MitoVES, thenoyltrifluoroacetone (TTFA) and Atpenin A5. We found that I56F and S68A SDHC variants, which support succinate-mediated respiration and maintain low intracellular succinate, were less efficiently inhibited by MitoVES than the wild-type (WT) variant. Importantly, associated ROS generation and cell death induction was also impaired, and cell death in the WT cells was malonate and catalase sensitive. In contrast, the S68A variant was much more susceptible to TTFA inhibition than the I56F variant or the WT CII, which was again reflected by enhanced ROS formation and increased malonate- and catalase-sensitive cell death induction. The R72C variant that accumulates intracellular succinate due to compromised CII activity was resistant to MitoVES and TTFA treatment and did not increase ROS, even though TTFA efficiently generated ROS at low succinate in mitochondria isolated from R72C cells. Similarly, the high-affinity Qp site inhibitor Atpenin A5 rapidly increased intracellular succinate in WT cells but did not induce ROS or cell death, unlike MitoVES and TTFA that upregulated succinate only moderately. These results demonstrate that cell death initiation upon CII inhibition depends on ROS and that the extent of cell death correlates with the potency of inhibition at the Qp site unless intracellular succinate is high. In addition, this validates the Qp site of CII as a target for cell death induction with relevance to cancer therapy.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010225
003      
CZ-PrNML
005      
20240314091310.0
007      
ta
008      
160408e20150507enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/cddis.2015.110 $2 doi
024    7_
$a 10.1038/cddis.2015.110 $2 doi
035    __
$a (PubMed)25950479
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kluckova, K $u Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
245    10
$a Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation / $c K. Kluckova, M. Sticha, J. Cerny, T. Mracek, L. Dong, Z. Drahota, E. Gottlieb, J. Neuzil, J. Rohlena,
520    9_
$a Respiratory complex II (CII, succinate dehydrogenase, SDH) inhibition can induce cell death, but the mechanistic details need clarification. To elucidate the role of reactive oxygen species (ROS) formation upon the ubiquinone-binding (Qp) site blockade, we substituted CII subunit C (SDHC) residues lining the Qp site by site-directed mutagenesis. Cell lines carrying these mutations were characterized on the bases of CII activity and exposed to Qp site inhibitors MitoVES, thenoyltrifluoroacetone (TTFA) and Atpenin A5. We found that I56F and S68A SDHC variants, which support succinate-mediated respiration and maintain low intracellular succinate, were less efficiently inhibited by MitoVES than the wild-type (WT) variant. Importantly, associated ROS generation and cell death induction was also impaired, and cell death in the WT cells was malonate and catalase sensitive. In contrast, the S68A variant was much more susceptible to TTFA inhibition than the I56F variant or the WT CII, which was again reflected by enhanced ROS formation and increased malonate- and catalase-sensitive cell death induction. The R72C variant that accumulates intracellular succinate due to compromised CII activity was resistant to MitoVES and TTFA treatment and did not increase ROS, even though TTFA efficiently generated ROS at low succinate in mitochondria isolated from R72C cells. Similarly, the high-affinity Qp site inhibitor Atpenin A5 rapidly increased intracellular succinate in WT cells but did not induce ROS or cell death, unlike MitoVES and TTFA that upregulated succinate only moderately. These results demonstrate that cell death initiation upon CII inhibition depends on ROS and that the extent of cell death correlates with the potency of inhibition at the Qp site unless intracellular succinate is high. In addition, this validates the Qp site of CII as a target for cell death induction with relevance to cancer therapy.
650    _2
$a sekvence aminokyselin $7 D000595
650    _2
$a vazebná místa $7 D001665
650    _2
$a buněčná smrt $x fyziologie $7 D016923
650    _2
$a respirační komplex II $x chemie $x genetika $x metabolismus $x fyziologie $7 D042963
650    _2
$a lidé $7 D006801
650    _2
$a mitochondrie $x metabolismus $x fyziologie $7 D008928
650    _2
$a molekulární sekvence - údaje $7 D008969
650    _2
$a mutageneze cílená $7 D016297
650    _2
$a konformace proteinů $7 D011487
650    _2
$a ubichinon $x chemie $x genetika $x metabolismus $7 D014451
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sticha, M $u Faculty of Sciences, Charles University, Prague, Czech Republic.
700    1_
$a Cerny, J $u Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Mracek, T $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Dong, L $u School of Medical Science, Griffith University, Southport, Queensland, Australia.
700    1_
$a Drahota, Zdeněk, $d 1932- $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. $7 jn20000400531
700    1_
$a Gottlieb, E $u The Beatson Institute for Cancer Research, Glasgow, UK.
700    1_
$a Neuzil, J $u 1] Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic [2] School of Medical Science, Griffith University, Southport, Queensland, Australia.
700    1_
$a Rohlena, J $u Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
773    0_
$w MED00173233 $t Cell death & disease $x 2041-4889 $g Roč. 6 (20150507), s. e1749
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25950479 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20240314091304 $b ABA008
999    __
$a ok $b bmc $g 1113654 $s 934593
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 6 $c - $d e1749 $e 20150507 $i 2041-4889 $m Cell death & disease $n Cell Death Dis $x MED00173233
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...